GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Bangkok Lab and Cosmetic PCL (BKK:BLC) » Definitions » COGS-to-Revenue

Bangkok Lab and Cosmetic PCL (BKK:BLC) COGS-to-Revenue : 0.43 (As of Mar. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Bangkok Lab and Cosmetic PCL COGS-to-Revenue?

Bangkok Lab and Cosmetic PCL's Cost of Goods Sold for the three months ended in Mar. 2024 was ฿157 Mil. Its Revenue for the three months ended in Mar. 2024 was ฿365 Mil.

Bangkok Lab and Cosmetic PCL's COGS to Revenue for the three months ended in Mar. 2024 was 0.43.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Bangkok Lab and Cosmetic PCL's Gross Margin % for the three months ended in Mar. 2024 was 56.99%.


Bangkok Lab and Cosmetic PCL COGS-to-Revenue Historical Data

The historical data trend for Bangkok Lab and Cosmetic PCL's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bangkok Lab and Cosmetic PCL COGS-to-Revenue Chart

Bangkok Lab and Cosmetic PCL Annual Data
Trend Dec21 Dec22 Dec23
COGS-to-Revenue
0.48 0.43 0.44

Bangkok Lab and Cosmetic PCL Quarterly Data
Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
COGS-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.43 0.43 0.45 0.44 0.43

Bangkok Lab and Cosmetic PCL COGS-to-Revenue Calculation

Bangkok Lab and Cosmetic PCL's COGS to Revenue for the fiscal year that ended in Dec. 2023 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=615.071 / 1406.184
=0.44

Bangkok Lab and Cosmetic PCL's COGS to Revenue for the quarter that ended in Mar. 2024 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=157.041 / 365.113
=0.43

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Bangkok Lab and Cosmetic PCL  (BKK:BLC) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Bangkok Lab and Cosmetic PCL's Gross Margin % for the three months ended in Mar. 2024 is calculated as:

Gross Margin %=1 - COGS to Revenue
=1 - Cost of Goods Sold / Revenue
=1 - 157.041 / 365.113
=56.99 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.


Bangkok Lab and Cosmetic PCL COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Bangkok Lab and Cosmetic PCL's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Bangkok Lab and Cosmetic PCL (BKK:BLC) Business Description

Traded in Other Exchanges
N/A
Address
Nong Chae Sao Road, No. 48/1 Moo 5, Nam Phu, Mueang Ratchaburi, Ratchaburi, Bangkok, THA, 70000
Bangkok Lab and Cosmetic PCL are one of Thailand's comprehensive healthcare solutions groups. Its operation covers the complete value chain of the healthcare business. Its product portfolio comprises generic and new generic drugs, herbal medicines, animal medicines, cosmetics, food supplements, and other health products. Its operation ranges from research and development, manufacturing with international standards, sales, and marketing, to distribution to partnering businesses and customers.

Bangkok Lab and Cosmetic PCL (BKK:BLC) Headlines

No Headlines